Trial · NCT00443053
Adverse events80
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 80
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Headache | Nervous system disorders | Fondaparinux 2.5 mg | 34 | 1,499 | |
| other | Headache | Nervous system disorders | Placebo | 31 | 1,488 | |
| other | Injection site hematoma | Skin and subcutaneous tissue disorders | Fondaparinux 2.5 mg | 27 | 1,499 | |
| other | Injection site hematoma | Skin and subcutaneous tissue disorders | Placebo | 17 | 1,488 | |
| other | Hypertension | Vascular disorders | Fondaparinux 2.5 mg | 20 | 1,499 | |
| other | Hypertension | Vascular disorders | Placebo | 15 | 1,488 | |
| other | Asthenia | General disorders | Fondaparinux 2.5 mg | 14 | 1,499 | |
| other | Asthenia | General disorders | Placebo | 16 | 1,488 | |
| serious | Angina pectoris | Cardiac disorders | Fondaparinux 2.5 mg | 0 | 1,499 | |
| serious | Angina pectoris | Cardiac disorders | Placebo | 1 | 1,488 | |
| serious | Atrial fibrillation | Cardiac disorders | Fondaparinux 2.5 mg | 0 | 1,499 | |
| serious | Atrial fibrillation | Cardiac disorders | Placebo | 1 | 1,488 | |
| serious | Cardiac failure acute | Cardiac disorders | Fondaparinux 2.5 mg | 0 | 1,499 | |
| serious | Cardiac failure acute | Cardiac disorders | Placebo | 1 | 1,488 | |
| serious | Coronary artery disease | Cardiac disorders | Fondaparinux 2.5 mg | 0 | 1,499 | |
| serious | Coronary artery disease | Cardiac disorders | Placebo | 2 | 1,488 | |
| serious | Myocardial infarction | Cardiac disorders | Fondaparinux 2.5 mg | 0 | 1,499 | |
| serious | Myocardial infarction | Cardiac disorders | Placebo | 1 | 1,488 | |
| serious | Right ventricular failure | Cardiac disorders | Fondaparinux 2.5 mg | 1 | 1,499 | |
| serious | Right ventricular failure | Cardiac disorders | Placebo | 0 | 1,488 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00443053/events